Noctera® CLINICAL TRIALS

The clinical evidence behind Noctera®

Noctera is a daily supplement designed to help with sleep disruptions caused by the hormonal changes that occur during perimenopause and menopause.* Below is a summary of the clinical evidence supporting the efficacy of Noctera.


  • 4 clinical studies
  • Includes randomized, double-blind placebo controlled trial
  • Data published in peer-reviewed, indexed journal


Noctera has been evaluated in four clinical studies involving women with sleep disturbances. One of these studies has had results published, including in SLEEP (the official journal of the sleep research society).

Bonafide requires clinical testing for most products. This approach gives both our customers and healthcare providers confidence that our products are safe and effective and that our claims are supported by rigorous evidence. 

Noctera for Sleep Support

Noctera® TRIAL 1

88% of women with moderate-to-severe sleep disturbances reached normal levels in 3 weeks

In a randomized, double-blind, placebo-controlled study of Noctera with 127 women conducted over three weeks, Noctera reduced sleep disturbances in as early as one week. 88% of patients with moderate-to-severe sleep disturbances improved to “within normal limits” by week three. And 83% of participants reported improved sleep quality. Total sleep time increased in the Noctera group by 40 minutes vs. decreased by 15 minutes in the placebo group by week three.

Carbonneau et al. Sleep. 2025;48(Supplement_1):A402-A403. Sleep disturbance (perceived difficulty falling or staying asleep and dissatisfaction with sleep quality) was measured via the PROMIS Sleep Disturbance, a validated patient-reported questionnaire assessing sleep disturbance over the prior 7 days. Scores are standardized T-scores; higher scores indicate greater disturbance (<55 normal, 55–59 02 mild, 60–69 moderate, ≥70 severe). Full data on file.

Find the studyOpens in a new window.
  • RCT

    randomized, double-blind, placebo-controlled trial

  • 127 women

    study size

  • Published

    in SLEEP, the official journal of the Sleep Research Society

Noctera® TRIAL 2

Sleep quality continued to improve over three months of use

In an open-label trial with 85 patients, sleep quality continued to improve with 3 months of use, with 88% of women reporting improved sleep satisfaction. When patients stopped taking Noctera, sleep quality worsened, showing that this product works best when used consistently long-term. In this study, Noctera was determined to be non-habit forming and non-sedative.

Open-label clinical trial. Data on File.

  • Open label

    open-label clinical trial

  • 85 women

    study size

  • Long-term

    sleep outcomes

Learn more about Noctera

See the full product page, ingredients, and how to get started.

SHOP NOCTERA
Noctera for Sleep Support